Web Analytics

3 Latest Announced Rounds

  • $34,000,000
    Seed

    1 Investors

    Technology, Information and Internet
    Jul 4th, 2025
  • $5,500,000
    Seed

    1 Investors

    Software Development
    Jul 4th, 2025
  • $28,500,000
    Series A

    2 Investors

    Venture Capital and Private Equity Principals
    Jul 4th, 2025
$840.57M Raised in 47 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Circulate

start up
United States - Seattle, Washington
  • 04/07/2025
  • Seed
  • $12,000,000

We are pioneering technologies and treatments to reverse aging and improve health outcomes. Rigorous scientific research is at the core of what we do. We are committed to innovating how people live healthier and longer lives by centering our approach on extensive research and clinical trials. Therapeutic Plasma Exchange (TPE) by Circulate is an evidence-based treatment that removes toxic, inflammatory, disease-causing and age-accelerating substances from the bloodstream. Our patented flagship product is improving lives today.


Related People

Brad YounggrenFounder

Brad Younggren United States - Seattle, Washington

CEO & Co-founder, Circulate
Previous Roles:
President (98point6)
Chief Medical Officer (4x) (98point6, Cue Health, Shift Labs, Mobisante)
Board Member Eastside Research Associates, Cardiogenics
Current Advisory Board: TBD Health, Violett , AlliConnect, Calmwave, 98point6
Previous Advisory role: Crescent Health (acquired) Blumio (acquired), Highway 1, Cue Med, Misceo
Emergency Physician